Max Healthcare Institute Limited

Max Healthcare Institute Limited (MAXHEALTH) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Hospital

maxhealthcare.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹994.90
Market cap
96,781 Cr
Stock P/E
76.4
P/B
9.00
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales1,363 Cr1,335 Cr1,423 Cr1,543 Cr1,707 Cr1,868 Cr1,910 Cr2,028 Cr2,135 Cr2,068 Cr2,143 Cr2,366 Cr
Operating expenses (approx.)976 Cr949 Cr1,041 Cr1,156 Cr1,257 Cr1,369 Cr1,398 Cr1,505 Cr1,560 Cr1,529 Cr1,536 Cr1,768 Cr
EBITDA387 Cr386 Cr382 Cr387 Cr451 Cr499 Cr512 Cr523 Cr575 Cr538 Cr606 Cr598 Cr
OPM %28.4%28.9%26.8%25.1%26.4%26.7%26.8%25.8%26.9%26.0%28.3%25.3%
Other income45 Cr46 Cr45 Cr35 Cr41 Cr33 Cr47 Cr37 Cr33 Cr45 Cr48 Cr41 Cr
Interest9 Cr11 Cr21 Cr24 Cr34 Cr52 Cr55 Cr55 Cr54 Cr60 Cr67 Cr71 Cr
Depreciation58 Cr61 Cr70 Cr77 Cr84 Cr98 Cr101 Cr104 Cr108 Cr111 Cr123 Cr132 Cr
Profit before tax366 Cr360 Cr336 Cr321 Cr374 Cr309 Cr403 Cr400 Cr446 Cr365 Cr465 Cr436 Cr
Tax %24.5%19.6%25.1%26.5%24.6%22.7%20.7%23.1%-10.1%17.5%26.3%26.0%
Net profit277 Cr289 Cr252 Cr236 Cr282 Cr239 Cr319 Cr308 Cr491 Cr301 Cr342 Cr323 Cr
EPS (₹)₹2.85₹2.98₹2.59₹2.43₹2.90₹2.46₹3.28₹3.17₹5.05₹3.10₹3.52₹3.32

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,505 Cr3,931 Cr4,563 Cr5,406 Cr7,028 Cr8,373 CrSign in for TTM
Operating expenses (approx.)2,101 Cr2,989 Cr3,322 Cr3,914 Cr5,180 Cr6,131 CrSign in for TTM
EBITDA404 Cr943 Cr1,241 Cr1,492 Cr1,849 Cr2,243 CrSign in for TTM
OPM %16.1%24.0%27.2%27.6%26.3%26.8%Sign in for TTM
Other income115 Cr127 Cr139 Cr178 Cr156 Cr163 CrSign in for TTM
Interest179 Cr101 Cr84 Cr60 Cr165 Cr235 CrSign in for TTM
Depreciation174 Cr221 Cr232 Cr245 Cr359 Cr447 CrSign in for TTM
Profit before tax-92 Cr739 Cr1,064 Cr1,365 Cr1,406 Cr1,676 CrSign in for TTM
Tax %-50.0%18.1%-3.7%22.5%23.5%13.9%Sign in for TTM
Net profit-138 Cr605 Cr1,104 Cr1,058 Cr1,076 Cr1,442 CrSign in for TTM
EPS (₹)₹-1.59₹6.25₹11.38₹10.89₹11.07₹14.83Sign in for TTM
Dividend payout %—0.0%0.0%9.2%13.5%10.1%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital966 Cr970 Cr971 Cr972 Cr972 Cr973 Cr
Reserves4,673 Cr5,313 Cr6,439 Cr7,436 Cr8,409 Cr9,774 Cr
Borrowings897 Cr727 Cr689 Cr1,299 Cr3,010 Cr3,478 Cr
Other liabilities2,009 Cr2,180 Cr2,003 Cr2,293 Cr2,823 Cr3,006 Cr
Total liabilities8,544 Cr9,189 Cr10,102 Cr12,000 Cr15,214 Cr17,231 Cr
Fixed assets (net)1,748 Cr1,954 Cr2,019 Cr3,246 Cr5,462 Cr6,980 Cr
CWIP27 Cr105 Cr207 Cr445 Cr900 Cr592 Cr
Investments0.51 Cr0.51 Cr0.51 Cr65 Cr8 Cr10 Cr
Loans & advances5 Cr3 Cr0 Cr0 Cr10 Cr0 Cr
Inventories54 Cr61 Cr76 Cr80 Cr106 Cr114 Cr
Trade receivables366 Cr385 Cr336 Cr463 Cr687 Cr970 Cr
Cash & bank627 Cr309 Cr43 Cr980 Cr662 Cr666 Cr
Other assets5,717 Cr6,372 Cr7,421 Cr6,721 Cr7,379 Cr7,899 Cr
Total assets8,544 Cr9,189 Cr10,102 Cr12,000 Cr15,214 Cr17,231 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity—748 Cr1,209 Cr1,122 Cr1,460 Cr1,633 Cr
Cash from investing—-772 Cr-1,187 Cr-1,285 Cr-1,632 Cr-1,689 Cr
Cash from financing—-294 Cr-289 Cr-264 Cr-164 Cr59 Cr
Net cash flow—-317 Cr-266 Cr-429 Cr-336 Cr4 Cr
Free cash flow (OCF − Capex)—187 Cr874 Cr343 Cr494 Cr149 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %1.6%13.4%14.2%14.7%12.7%13.4%
ROE %-2.4%9.6%0.0%12.5%11.5%13.4%
Debtor days533627313642
Inventory days866565
Days payable634243464237
Cash conversion cycle-2-0-10-9-110
Debt / equity0.160.120.090.150.320.32
Current ratio1.451.321.861.370.880.89
Net debt / EBITDA0.000.000.520.211.271.25

Compare with peers

Loading peers…